However, ERBB2 expression in PC progression is more controversial, with one study showing that a high level of ERBB2 is associated with poor prognosis [36], as measured by BCR, while a previous study from our group failed to identify any correlation with BCR [37]. Here, BCR is linked to pachyonychia congenita.